Island secures Singapore patent for ISLA-101
Singapore grants patent covering use of ISLA-101 to treat flavivirus infections, including Dengue, and Chikungunya Patent remains until April 2034, strengthening long-term commercial exclusivity in key Asia-Pacific market New protection bolsters Island’s …